Introducing Flex, a program allowing you to access our latest technology with simple monthly payments.
When newly diagnosed with diabetes, it’s natural to feel overwhelmed, scared, uncertain, and confused, asking yourself, “What will my life be like now? You are not alone.
1.5 million Americans are diagnosed with diabetes every year.*
Insulin pump therapy provides more flexibility for your lifestyle while giving you greater control of your diabetes. The MiniMed™ 670G insulin pump system is revolutionary new technology that mimics some of the functions of a healthy pancreas.
Now approved for
ages 7 and up.†
of MiniMed™ 670G users said that it met or exceeded their expectations about improving overall health.
Ask real MiniMed™ 670G customers questions about life with the pump.
Whether your child was just diagnosed with diabetes or has been managing it for some time, Medtronic is the right place to turn for help. Over 250,000 families who have children with diabetes count on Medtronic and our diabetes products to secure their child's long-term health.
How To Love and Support Someone With Diabetes.
You have type 2 diabetes, but diabetes shouldn’t rule your life. You want to manage your sugar levels well, but with shots and oral medication, you must deal with frequent challenges to keep your sugar levels under control. You wish there was an easier way to manage insulin dosing without compromising your health. You’re not alone. Here you will find some useful information to help you learn more about Medtronic and treatment options.
Diabetes takes no breaks, neither do we. Your Medtronic family is always by your sideSM. Here are some quick links to pages you may be looking for.
Improved CareLink™ Personal Uploads. No Java™ required.
Diabetes never rests, but you are not alone. We’re with you on this journey. We’ve supported over 1.2 million people living with diabetes around the world. From your first training session to ongoing support, our global team is always there to help.
Our unparalleled service is the # 1 reason people with diabetes stay with us.
As Animas’ partner-of-choice, we're here to support you through every step in the process.
John refused to put his life on hold. He put all his energy into exploring ways to keep his glucose levels in range. Then he discovered that the MiniMed™ 670G system with SmartGuard™ technology automatically adjusts∆ insulin delivery to keep his glucose levels in check. He knew he could decrease the chance of dangerous highs and lows holding him or his family back.
Brett chooses to not just manage high and low glucose levels, but outsmart them with the Guardian™ Connect smart CGM system and Sugar.IQ™ diabetes assistant.
J.D. was put on an iPro™2 professional CGM evaluation to determine his glucose variability. Based on the results, his doctor prescribed a long-acting insulin.
* American Diabetes Association, statistics about diabetes.
∆ Refers to AutoMode. Some interaction required. Individual results may vary.
§ Customer training phase – data on file.
† WARNING (For MiniMed™ 670G System Users Ages 7-13):
The low sensor glucose alert functionality is distinct from the automated insulin dosing function of the MiniMed™ 670G system. When used in Auto Mode, the MiniMed™ 670G system has been shown to be safe and effective for its intended use in this population. However, do not rely solely on the use of a low sensor glucose (SG) value for “Alert on Low” or “Alert before Low” for alerts set at 50 mg/dL and 60 mg/dL. A low sensor glucose alert may not reflect the user’s true blood glucose at these levels or may not alert. Do not ignore symptoms of low glucose. Always confirm your sensor glucose readings with your blood glucose meter and treat according to the recommendations of your healthcare professional. Solely relying on these sensor glucose alerts and readings for treatment decisions could result in missing severe hypoglycemia (low blood glucose) events.
1 Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns.